Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1026 of 6351
-
Kids with CML may get a break from daily pills in new trial
Disease control OngoingThis phase II trial studies how stopping tyrosine kinase inhibitors will affect treatment-free remission in patients with chronic myeloid leukemia in chronic phase. When the level of disease is very low, it's called molecular remission. TKIs are a type of medication that help kee…
Phase 2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New hope for kidney transplant patients with cancer: drug combo aims to fight tumors without losing the donated kidney
Disease control OngoingThis phase I trial studies how well tacrolimus, nivolumab, and ipilimumab work in treating kidney transplant recipients with cancer that cannot be removed by surgery (unresectable) or has spread to other places in the body (metastatic). Tacrolimus may stop the growth of tumor cel…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New drug hopes to ease transfusion burden for kids with blood disorder
Disease control Recruiting nowThis is a Phase 2a study to evaluate the safety and pharmacokinetics (PK) of luspatercept in pediatric participants with β-thalassemia. The study will be conducted in 2 parts for both transfusion-dependent (TD) and non-transfusion-dependent (NTD) β-thalassemia participants: TD P…
Phase 2 • Sponsor: Celgene • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Can group prenatal care with social support reduce preterm births?
Prevention CompletedThis is a randomized comparative effectiveness study of two forms of enhanced prenatal care among 674 Medi-Cal eligible pregnant individuals in Fresno, California. The goal is to see whether group prenatal care with wrap around services versus individual prenatal care supplemente…
Sponsor: University of California, San Francisco • Aim: Prevention
Last updated Aug 19, 2026 00:00 UTC
-
Stem cell trick may free kidney patients from daily pills
Disease control Recruiting nowThe purpose of this study is to find out if an investigational treatment will allow kidney transplant recipients to better accept their new kidney and stop immunosuppressive medicines. This study is for kidney transplant recipients who receive a kidney from a sibling donor. The …
Phase 1/2 • Sponsor: Jeffrey Veale, MD • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New combo therapy shows promise in reducing veteran suicides
Disease control CompletedHigh rates of Veteran suicide remain a tragedy. Rates of Veteran suicide have not decreased for 10 years, despite the best efforts of the field. Those interventions that do exist have only modest effects, which are simply insufficient for the magnitude of the problem. This propos…
Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 26, 2026 14:39 UTC
-
A 'Bladder Pacemaker'? nerve stimulation may curb incontinence after spinal injury
Disease control CompletedBladder spasms after spinal cord injury (SCI) can result in incontinence, urinary tract infections, kidney damage, trigger dangerous increases in blood pressure and decrease independence and quality of life. The investigators' long-term goal is to develop and provide a "bladder p…
Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New combo therapy shows promise for tough liver cancer
Disease control OngoingA multicenter Phase II, randomized, prospective, open-label Trial investigating the clinical impact on combining Specific Internal Radiotherapy (SIRT) with the PD1-L Inhibitor Durvalumab and the CTLA-4 Inhibitor Tremelimumab in patients with intrahepatic Biliary Tract Cancer
Phase 2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Can the HPV vaccine stop cervical abnormalities from returning after surgery?
Prevention CompletedThe researchers involved in this new study are interested in whether giving a HPV vaccine to women at the same time as conisation can lead to a greater rate of HPV clearance compared to conisation on its own, and a result reduce the occurrence of further infection and high grade …
Phase 3 • Sponsor: Imperial College London • Aim: Prevention
Last updated Jun 27, 2026 12:28 UTC
-
Could a natural chemical be the key to safer heart failure treatment?
Disease control CompletedLCZ696, a molecular complex of the angiotensin receptor blocker (ARB) valsartan with an inhibitor of neprilysin (NEP, neutral endopeptidase-24.11) sacubitril improved mortality compared to enalapril in patients with heart failure (HF), reduced ejection fraction (EF), and increase…
Phase 4 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New drug combo aims to stall advanced prostate cancer
Disease control OngoingThe purpose of this study is to test the effectiveness (how well the drugs work), safety, and tolerability of the investigational drug combination of olaparib and AZD6738 for all patients with metastatic castration-resistant prostate cancer.
Phase 2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New drug cocktail targets Hard-to-Treat myeloma spread
Disease control OngoingThis trial will try to establish the feasibility and efficacy of the combination of DaraVCD in Multiple Myeloma (MM) patients presenting with extramedullary disease (EMD). The study will be conducted as a Phase II trial. Forty patients will be included in the study cohort. All p…
Phase 2 • Sponsor: Stichting European Myeloma Network • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
Can a simple drug make CAR-T therapy safer?
Disease control OngoingThis study is being done to see if the investigational drug, anakinra, prevent or reverse the severe side effects caused by CAR-T cell therapy.
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New study asks: can we stop myeloma meds if no cancer is found?
Disease control OngoingThis study is to assess for Measurable Residual Disease (MRD) in multiple myeloma at a deeper level than what is currently available by combining novel imaging and laboratory techniques, determine if patients who are MRD-negative by these multiple modalities can safely and effect…
Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Immunotherapy cocktail aims to boost immune attack on prostate tumors before surgery
Disease control Recruiting nowThis phase II trial studies how well atezolizumab works alone or in combination with etrumadenant or tocilizumab in treating men with localized prostate cancer before radical prostatectomy. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune…
Phase 2 • Sponsor: David Oh • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Can a biologic drug tame Crohn's without steroids? a large Real-World study investigates
Disease control CompletedThe purpose of this study is to capture the real-world experience of CD patients treated with ustekinumab as part of their clinical care in a variety of care settings from large teaching/research centres to smaller district hospitals.
Sponsor: University Hospital Southampton NHS Foundation Trust • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Weekly shot may halt arthritis progression in kids
Disease control CompletedThis is a research study to test whether a once-weekly injection of abatacept will prevent the progression of Juvenile Idiopathic Arthritis (JIA) to a more severe form. To evaluate the effectiveness of a 24-week course of treatment with abatacept plus usual care versus usual care…
Phase 3 • Sponsor: Duke University • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Could a stroke drug help dementia patients?
Disease control OngoingButylphthalide soft capsule has been confirmed to have beneficial effects for patients with vascular dementia (VaD) in clinical trial of phase II study. So the investigators hypothesize that Butylphthalide soft capsule may have same beneficial effects for patients with VaD in an …
Phase 3 • Sponsor: Capital Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could vitamin D3 boost chemo for advanced colon cancer?
Disease control OngoingThis phase III trial studies how well vitamin D3 given with standard chemotherapy and bevacizumab works in treating patients with colorectal cancer that has spread to other parts of the body. Vitamin D3 helps the body use calcium and phosphorus to make strong bones and teeth. Dru…
Phase 3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New pill shows promise for hard-to-treat ovarian cancer
Disease control CompletedA phase II, multi-center, open-label, single-arm, non-randomized study to evaluate the efficacy, safety and tolerability of IMP4297 capsules in subjects with germline and/or somatic BRCA1/2 mutated advanced ovarian cancer in china
Phase 2 • Sponsor: Impact Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC